SignatureFD’s Forma Therapeutics Holdings, Inc. Common Stock FMTX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
Sell
-402
Closed -$8K 3467
2022
Q3
$8K Buy
402
+90
+29% +$1.19K ﹤0.01% 2225
2022
Q2
$2K Buy
312
+83
+36% +$582 ﹤0.01% 2853
2022
Q1
$2K Buy
229
+167
+269% +$1.78K ﹤0.01% 2912
2021
Q4
$1K Buy
62
+28
+82% +$484 ﹤0.01% 3063
2021
Q3
$1K Buy
34
+5
+17% +$118 ﹤0.01% 2991
2021
Q2
$1K Buy
+29
New +$779 ﹤0.01% 2909

SignatureFD's FMTX Position: Q4 2022 in Review

SignatureFD sold out of Forma Therapeutics Holdings, Inc. Common Stock (FMTX) in Q4 2022, closing a stake of 402 shares — an estimated $8K sold.

SignatureFD first reported a position in FMTX in Q2 2021 and held it in 6 quarters. The position peaked at $8K in Q3 2022. 0 funds tracked by Wall St. Rank hold FMTX as of Q4 2022.

  • SignatureFD reported no remaining Forma Therapeutics Holdings, Inc. Common Stock position as of Q4 2022 after selling out during the quarter.
  • SignatureFD sold 402 Forma Therapeutics Holdings, Inc. Common Stock shares in Q4 2022, an estimated $8K.
  • SignatureFD first reported a position in Forma Therapeutics Holdings, Inc. Common Stock in Q2 2021 and held it in 6 quarters.
  • SignatureFD's Forma Therapeutics Holdings, Inc. Common Stock position peaked at $8K in Q3 2022.
  • 0 funds tracked by Wall St. Rank held Forma Therapeutics Holdings, Inc. Common Stock as of Q4 2022.

Based on SignatureFD's 13F filing for Q4 2022, filed 30 Jan 2023.